Given the protective role of Sb9 in regulating cell apoptosis, the modulation of homeostasis between Sb9 and GzmB emerges as a potential therapeutic strategy for various conditions, including cancers (30), HIV, autoimmune disorders (36, 84), renal transplantation (70), and hepatitis (107). The gene discussed is GZMB; the disease is cancer.